Compounds > propionylcarnitine
Page last updated: 2024-08-26

propionylcarnitine and Kidney Diseases

propionylcarnitine has been researched along with Kidney Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bertelli, A; Carpi, A; Filippi, C; Giovannini, L; Migliori, M; Origlia, N; Panichi, V1
Al-Majed, AA; Al-Rejaie, SS; Al-Shabanah, OA; Al-Yahya, AA; Aleisa, AM; Bakheet, SA; Sayed-Ahmed, MM1
Andreini, B; Bertelli, A; Giovannini, L; Migliori, M; Palla, R; Panichi, V1

Other Studies

3 other study(ies) available for propionylcarnitine and Kidney Diseases

ArticleYear
Protective effect of L-propionylcarnitine in chronic cyclosporine-a induced nephrotoxicity.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2006, Volume: 60, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Carnitine; Creatinine; Cyclosporine; Immunosuppressive Agents; Kidney Diseases; Lipid Peroxidation; Male; Rats; Rats, Wistar

2006
Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues.
    Clinical and experimental pharmacology & physiology, 2007, Volume: 34, Issue:12

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Antineoplastic Agents; Blood Urea Nitrogen; Carnitine; Cisplatin; Creatinine; Glutathione; Kidney Diseases; Male; Nitrates; Nitrites; Protective Agents; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances

2007
Protective effect of L-propionylcarnitine on cyclosporine-induced nephrotoxicity.
    Drugs under experimental and clinical research, 1995, Volume: 21, Issue:6

    Topics: Analysis of Variance; Animals; Carnitine; Cyclosporine; Dose-Response Relationship, Drug; Kidney Diseases; Male; Rats; Rats, Wistar

1995